Episodes

  • Steven Cress' Top 2 Stocks H2 2026

    Steven Cress' Top 2 Stocks H2 2026
    Jul 16 2026
    Steven Cress, Seeking Alpha's Head of Quant, discusses the economic and geopolitical shocks that have shaped 2026, and how it's created buy the dip opportunities (1:30) Why quant? (16:40) Top 2 stocks for H2 '26 (34:00)

    Show Notes:
    Top 10 Stocks For H2 2026
    Top Stocks For H2 2026! (Replay)
    Steven Cress' Top 10 Stocks For 2026

    Episode transcripts

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show More Show Less
    38 mins
  • Predicting S&P 500 at 6,300 - 6,500 by year end

    Predicting S&P 500 at 6,300 - 6,500 by year end
    Jul 15 2026
    Sanjeev Sharma explains his S&P 500 prediction for 2026 (0:35) LLMs, AI effects, and semis (10:40)

    Show Notes:
    S&P 500 Will Be Around 6,300 By The End Of 2026
    S&P 500: 7,000 Target For 2025 - Sanjeev Sharma

    Episode transcripts

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show More Show Less
    26 mins
  • Steven Cress' top 10 stocks for 2026 (mid-year review)

    Steven Cress' top 10 stocks for 2026 (mid-year review)
    Jul 9 2026
    Seeking Alpha's Head of Quant, Steve Cress, provides a mid-year update on his top 10 stocks for 2026.

    Show Notes:
    Steven Cress' Top 10 Stocks For 2026
    2026 Top Stocks Mid-Year Performance Review (Video)

    Episode transcripts

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show More Show Less
    31 mins
  • Biotech euphoria driven by fundamentals

    Biotech euphoria driven by fundamentals
    Jul 8 2026
    Jonathan Faison, who runs ROTY Biotech Community, says recent biotech euphoria driven by fundamentals and M&A appetite (0:50) 3 $10B+ buyouts with Nuvalent, Apogee, and Crinetics (2:15) Sector ETFs and metrics to focus on (7:00) Bullish on Journey Medical (14:40)

    Show Notes:
    Vertex to acquire Crinetics Pharmaceuticals in $10B deal
    Making Money In Biotech Stocks

    Episode transcripts

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show More Show Less
    30 mins
  • We're in (the early stages of) a bubble

    We're in (the early stages of) a bubble
    Jul 7 2026
    Analyst Clem Chambers explains the market's big shuffle (0:30) Be on the road to diversification (6:15) 25% = natural limit to long-term returns (12:00) Look at simple technicals and financials, be suspicious of words (16:40) Soft spot for ETFs (24:55) Highlighting Neo Performance Materials (31:45)

    Show Notes:
    How Much Further Will Gold And Silver Run?
    Intel Stock: Why The Trump Call Won't Fail
    aNewFN

    Episode transcripts

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show More Show Less
    55 mins
  • Tax alpha with Raul Shah: Roth conversions

    Tax alpha with Raul Shah: Roth conversions
    Jul 1 2026
    Welcome back to our new series on Investing Experts, Tax Alpha with Raul Shah! Roth conversions, one of the most powerful tax planning strategies (2:25) Your tax bracket today, your future tax bracket (6:30) Who should be using Roth conversions? (11:35) Personal finance is personal (16:50) When conversions don't make sense (19:15)

    Show Notes:
    Tax Alpha With Raul Shah: Thoughtful Asset Location
    UnitedHealth, Hims & Hers, Gambling.Com - Value Investing With Raul Shah

    Episode transcripts

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show More Show Less
    28 mins
  • Great market expectations

    Great market expectations
    Jun 17 2026
    Next-gen investing experts Julia Ostian, Kenio Fontes, and Jack Bowman share their thoughts on today's market (0:20). Kevin Warsh's 1st meeting; market's a little too hawkish (3:00) SpaceX IPO bewilderment (6:00) AI dominance (7:20) Meta: 2 bulls, 1 contrarian (25:50) How to properly value tech stocks (38:45) Private credit picks (52:00)

    Show Notes:
    SpaceX: The Most Misunderstood IPO In Decades
    The Terrifying Truth Behind The SpaceX IPO
    The Fed Is Looking Through The May CPI Report

    Episode transcripts

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show More Show Less
    1 hr
  • What's driving the price of gold

    What's driving the price of gold
    Jun 16 2026
    Axel Merk, who manages ~$4 billion in the precious metal space, explains how the market pushed him back into gold (0:30) Why price of gold has been so sensitive (3:45) Investing in gold and the miners (6:00) ETFs not well suited for miners (9:20) Silver is challenging (14:30) Gold price hostage to what's happening in Iran (16:00) If inflation goes up, why currency at times moves higher (19:55) Polarized FOMC, Kevin Warsh's first statement (28:05)

    Episode transcripts

    For full access to analyst ratings, stock and ETF quant scores, and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show More Show Less
    43 mins